| Chronic administration of pharmacological doses of angiotensin 1‐7 and iodoangiotensin 1‐7 has minimal effects on blood pressure, heart rate, and cognitive function of … FF Stoyell‐Conti, A Chabbra, J Puthentharayil, K Rigatto, RC Speth Physiological reports 9 (7), e14812, 2021 | 8 | 2021 |
| Preliminary study of ovariectomy and chronic losartan-induced alterations in brain AT1 receptors D Mehranfard, A Linares, A Chabbra, G Campos, AMA de Souza, H Ji, ... Brain Research 1766, 147520, 2021 | 2 | 2021 |
| 125‐I‐Sarcosine (1), D‐Alanine (8) Angiotensin II as a Biased Radioligand for AT1 Angiotensin II Receptors RC Speth, N Desai, A Chabbra, G Gnozzo, FF Stoyell-Conti, CA West The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Preliminary Characterization of the 125I‐Angiotensin 1‐7 Binding Site in Rodent Liver FF Stoyell-Conti, A Chabbra, RC Speth The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Pyridoxal 5 Phosphate Decarboxylates Angiotensin II: Putative Mechanism for Generation of Angiotensin A FF Stoyell-Conti, A Chabbra, R Perry, RC Speth The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Development of" Sharkavir": A Hypothetical Inhibitor for HIV-1 Protease M Hunt, F Abbas, L Abbas, M Ghali, H Ghali, A Chabbra, E Schmitt Lavin, ... | | 2020 |
| Searching for the Elusive Angiotensin-1-7 Receptor RC Speth, F Fernandes Conti, A Chabbra | | 2020 |
| Developing a Physical Model of HigB Toxin and its Endonuclease Cleavage Mechanism A Chabbra, C Alzamora, H Ghali, M Handal, M Kathiria, A Martinek, ... The FASEB Journal 33 (S1), 454.3-454.3, 2019 | | 2019 |
| Developing a physical model of O‐GlcNAc transferase (OGT) in complex with TAB1 VP Hernandez, S Nguyen, A Chabbra, EF Schmitt Lavin The FASEB Journal 32, 663.23-663.23, 2018 | | 2018 |
| Protein Modeling A Chabbra | | 2018 |
| Developing a Molecular Model to Explain the Role of O-GlcNAc Transferase (OGT) in O-GlcNAcylation VP Hernandez, S Nguyen, A Chabbra | | 2018 |
